Obigen Pharma Inc. (TPEX:7876)
Taiwan · Delayed Price · Currency is TWD 37.70
+0.30 (0.80%)
At close: Sep 7, 2026
Obigen Pharma Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | -414.33 | -325.96 | -274.31 | -245.29 | -218.21 |
Depreciation & Amortization | 112.14 | 113.96 | 111.3 | 106.55 | 100.82 |
Other Amortization | 0.73 | 0.73 | 0.74 | - | - |
Stock-Based Compensation | 16.99 | 13.01 | 17.24 | 40.11 | 10.98 |
Other Operating Activities | 0.93 | 0.08 | 1.03 | 0.39 | 0.04 |
Change in Accounts Receivable | 0.18 | 0.36 | -0.53 | -0.83 | -0.01 |
Change in Accounts Payable | -2.77 | -5.37 | 11.41 | 4.31 | 0.98 |
Change in Other Net Operating Assets | -41.13 | -40.07 | -9.01 | -7.68 | -11.93 |
Operating Cash Flow | -327.26 | -243.26 | -142.13 | -102.44 | -117.32 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Capital Expenditures | -8.58 | -5.71 | -26.63 | -25.15 | -161.37 |
Sale (Purchase) of Intangibles | - | - | -1.49 | - | - |
Investment in Securities | 290 | 181.7 | 127.6 | -739.3 | - |
Other Investing Activities | 0.83 | 0.04 | -0.02 | -2.27 | -2.4 |
Investing Cash Flow | 282.25 | 176.02 | 99.46 | -766.72 | -163.77 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Long-Term Debt Repaid | - | -14.8 | -13.01 | -6.73 | -6.62 |
Lease Payments | -16.68 | -14.8 | -13.01 | -6.73 | -6.62 |
Net Debt Issued (Repaid) | -16.68 | -14.8 | -13.01 | -6.73 | -6.62 |
Issuance of Common Stock | 25.18 | 20.55 | - | 652.48 | 307.53 |
Other Financing Activities | -0.55 | - | -0 | 0.55 | 0 |
Financing Cash Flow | 7.95 | 5.75 | -13.01 | 646.3 | 300.9 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Cash Flow | -37.06 | -61.49 | -55.68 | -222.87 | 19.81 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -335.84 | -248.98 | -168.76 | -127.59 | -278.7 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -3.15 | -2.34 | -1.59 | -1.25 | -3.67 |
Levered Free Cash Flow | -189.33 | -136.91 | -75.23 | -47.8 | - |
Unlevered Free Cash Flow | -188.45 | -135.83 | -73.98 | -46.79 | - |
Free Cash Flow After Leases | -352.51 | -263.77 | -181.77 | -134.32 | -285.32 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash Interest Paid | 1.4 | 1.72 | 2.77 | 0.85 | 0.96 |
Change in Working Capital | -43.72 | -45.08 | 1.88 | -4.19 | -10.95 |